Therefore, apocrine carcinomas may be divided into two BC subtypes based on human epidermal growth factor receptor-2 (HER2) status: triple negative breast cancer (TNBC) and HER2-positive BC1,3. This evidence concerns the gene ERBB2 and breast cancer.